Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CA2D1 | P54289 | Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1] | FDA approved drug targetsPlasma proteinsPredicted intracellular proteins | 1 | EpilepsyIntellectual disabilityAnxiety disorder | Clinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| CA2D2 | Q9NY47 | Voltage-dependent calcium channel subunit alpha-2/delta-2 (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2] | Disease related genesFDA approved drug targetsPredicted intracellular proteins | 1 | Epilepsy | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| CABP8 | Q9BXU9 | Calcium-binding protein 8 (CaBP8) (Calneuron I) (Calneuron-1) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediation | 1 | 0.53 | |||
| CAC1C | Q13936 | Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) | Disease related genesFDA approved drug targetsHuman disease related genes | 24 | AutismAutism spectrum disorderBrugada syndrome | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.53 | ||
| CAC1E | Q15878 | Voltage-dependent R-type calcium channel subunit alpha-1E (Brain calcium channel II) (BII) (Calcium channel, L type, alpha-1 polypeptide, isoform 6) (Voltage-gated calcium channel subunit alpha Cav2.3) | 24 | Heart failureUnspecific body region injury | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.53 | |||
| CAD10 | Q9Y6N8 | Cadherin-10 (T2-cadherin) | Predicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.53 | |||
| CAD19 | Q9H159 | Cadherin-19 | Predicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.53 | |||
| CAD26 | Q8IXH8 | Cadherin-like protein 26 (Cadherin-like protein VR20) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediation | 1 | 0.53 | |||
| CADH1 | P12830 | Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3] | Cancer-related genesCD markersDisease related genes | 1 | Ectodermal dysplasia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| CADH2 | P19022 | Cadherin-2 (CDw325) (Neural cadherin) (N-cadherin) (CD antigen CD325) | CD markersDisease related genesHuman disease related genes | 1 | CardiomyopathyIntellectual disabilitySolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 |